Remarkably, increased survivin expression has been observed in the most common human neoplasm, including oesophageal cancer [6], ovarian carcinoma[7], laryngeal squamous cell carcinoma [8], colorectal carcinoma [5], breast carcinoma[9] and lymphoma[10]. Here, BIRC5 is linked to lymphoma.